138 Natural history of atrial fibrillation and atrial fibrillation ablation in patients undergoing percutaneous atrial septal defect closure

Carpenter, Alexander; Crowther, Oliver; Gall, Alexander; Elgamal, Sarah Moharem; Bennett, Richard G.; Mehisen, Mohamed; Turner, Mark A.; Nisbet, Ashley

doi:10.1136/heartjnl-2019-bcs.135

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…В ряде исследований было выдвинуто предположение о том, что закрытие ООО может рассматриваться в качестве фактора, снижающего частоту рецидивов ФП. Так, в результатах не-скольких метаанализов, включавших более 5 000 пациентов, которым выполнялось хирургическое или эндоваскулярное закрытие ООО или дефекта межпредсердной перегородки, было продемонстрировано достоверное снижение распространенности ФП в течение 5 лет [23,24].…”

Section: таблица 1 динамика показателей эхо-кг в течение периода набл...unclassified

“…В 2019 г. были опубликованы результаты длительного наблюдения за 384 пациентами с ДМПП, которым выполнялось эндоваскулярное закрытие дефекта. У 74 больных отмечалась ФП, 15 пациентов перенесли РЧА до имплантации окклюдера [23]. В течение периода наблюдения у 36% пациентов с ФП, которым не выполнялась последующая РЧА, ФП не рецидивировала в течение одного года после закрытия ДМПП, а среди 289 пациентов без ранее существовавшей ФП частота манифестации составила 0,3% [26].…”

Section: таблица 1 динамика показателей эхо-кг в течение периода набл...unclassified

See 1 more Smart Citation

Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers

Tereshchenko,

Zhelyakov,

Merkulov

et al. 2024

Evrazijskij kardiologičeskij žurnal

View full text Add to dashboard Cite

The volume of the left atrium is one of the key factors associated with both the development of primary atrial fibrillation and its progression. Open atrial communication is considered as a factor predisposing to dilation and remodeling of the heart cavities. We present a clinical case of endovascular closure of an open oval window in a patient with a persistent form of AF, a moderately reduced left ventricular ejection fraction, who had previously undergone radiofrequency ablation, and persistent manifestations of heart failure. A 58-year-old patient was hospitalized in November 2019 with clinical manifestations of increasing heart failure. History: persistent form of atrial fibrillation with pronounced ventricular tachysystole. In April 2019, the patient underwent radiofrequency ablation, during which signs of open oval window were revealed. The initial left ventricular ejection fraction is 41%, the anterior–posterior left atrium size is 47 mm, the NT-proBNP level is 912 pg/m. In the subsequent period, steady sine waves were recorded.

show abstract

Section: таблица 1 динамика показателей эхо-кг в течение периода набл...unclassified

Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers

Tereshchenko,

Zhelyakov,

Merkulov

et al. 2024

Evrazijskij kardiologičeskij žurnal

View full text Add to dashboard Cite

show abstract

“…On the other hand, there is an assumption that the closure of the PFO may have an antiarrhythmic effect on AF. In this regard, the results of several meta-analyses including over 5000 patients who underwent interventional or surgical closure of the PFO or atrial septal defect, deserve attention, which indicate a significant decrease in the prevalence of AF after the intervention in the follow-up period of up to 5 years [18,19]. In 2019 Carpenter A. et al published the results of a long-term follow-up of 384 patients with an atrial septal defect who underwent interventional closure.…”

Section: Influence Of Pfo Closure On the Arrhythmic Syndromementioning

confidence: 99%

Endovascular Occlusion of the Patent Foramen Ovale as Part of Antiarrhythmic Treatment of a Patient With Persistent Atrial Fibrillation (Case Report)

Zhelyakov

Терещенко

Меркулов

et al. 2023

IAM

View full text Add to dashboard Cite

Below is a case report of treatment of a patient with persistent tachysystolic atrial fibrillation (AF), chronic heart failure (CHF) with a moderately reduced left ventricular ejection fraction (EF) and patent foramen ovale (PFO) with an atrial septal aneurysm. A 58-year-old man (with body mass index of 27.8 kg/ m2) with tachysystolic persistent AF (duration 3 months) was hospitalized due to an increase in CHF symptoms (CHF functional class according to NYHA is II-III). The patient had been constantly receiving therapy in accordance with current recommendations (angiotensin receptor blockers, diuretics, beta-blockers, amiodorone and rivaroxaban). Transthoracic echocardiography showed a moderate decrease in ejection fraction (EF) (41%), an increase in the left (47 mm) and right (51x74 mm) atria. The patient underwent AF radiofrequency catheter ablation (RFA) in the left atrium, which identified PFO. The final stage of RFA was performed by external electrical cardioversion with successful restoration of sinus rhythm. Four months after RFA, despite a stable sinus rhythm, the patient maintained a moderately reduced LV EF (44%) and dilatation of the left (44 mm) and right (43x65 mm) atria. Transesophageal echocardiography revealed an aneurysmally altered atrial septum and a positive bubble test with a large number of bubbles. In accordance with current recommendations, the patient had indications for primary prevention of stroke -endovascular occlusion of the PFO, which was performed. Three months after PFO closure, the patient discontinued diuretics, amiodarone, and rivaroxaban. Combined therapy in a patient with persistent AF, with a moderately reduced EF and verified PFO, which included pathogenetic therapy for CHF, prescription of antiarrhythmic drugs, RFA of the AF substrate, and interventional closure of the PFO, made it possible to effectively control sinus rhythm, significantly reduce the manifestations of CHF and provide primary prevention of embolic disorders.

show abstract

Endovascular occlusion of patent foramen ovale as antiarrhythmic treatment of atrial fibrillation

Ardashev,

Passman,

Efimov

et al. 2024

J Interv Card Electrophysiol

View full text Add to dashboard Cite

138 Natural history of atrial fibrillation and atrial fibrillation ablation in patients undergoing percutaneous atrial septal defect closure

Cited by 3 publications

References 0 publications

Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers

Case report: the effect of endovascular closure of an open oval window on the course of atrial fibrillation and the processes of reverse remodeling of the heart chambers

Endovascular Occlusion of the Patent Foramen Ovale as Part of Antiarrhythmic Treatment of a Patient With Persistent Atrial Fibrillation (Case Report)

Endovascular occlusion of patent foramen ovale as antiarrhythmic treatment of atrial fibrillation

Contact Info

Product

Resources

About